000 01027 a2200289 4500
005 20250516085425.0
264 0 _c20121019
008 201210s 0 0 eng d
022 _a1432-1238
024 7 _a10.1007/s00134-012-2552-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWetzel, Léonore
245 0 0 _aLess blood loss with tetrastarch.
_h[electronic resource]
260 _bIntensive care medicine
_cJun 2012
300 _a1078-9; author reply1080-1 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aFemale
650 0 4 _aHemostasis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxyethyl Starch Derivatives
_xpharmacology
650 0 4 _aMale
650 0 4 _aPlasma Substitutes
_xpharmacology
650 0 4 _aThrombelastography
_xinstrumentation
700 1 _aKozek-Langenecker, Sibylle
773 0 _tIntensive care medicine
_gvol. 38
_gno. 6
_gp. 1078-9; author reply1080-1
856 4 0 _uhttps://doi.org/10.1007/s00134-012-2552-x
_zAvailable from publisher's website
999 _c21693690
_d21693690